Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Watchlist
Price: 8.86 USD 1.03% Market Closed
Market Cap: 1.3B USD
Have any thoughts about
Aurinia Pharmaceuticals Inc?
Write Note

Relative Value

The Relative Value of one AUPH stock under the Base Case scenario is 15.18 USD. Compared to the current market price of 8.86 USD, Aurinia Pharmaceuticals Inc is Undervalued by 42%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AUPH Relative Value
Base Case
15.18 USD
Undervaluation 42%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
82
vs Industry
68
Median 3Y
8.7
Median 5Y
23.7
Industry
7.7
Forward
5.3
vs History
vs Industry
Median 3Y
-13.8
Median 5Y
-13.2
Industry
22.7
Forward
744
vs History
0
vs Industry
Median 3Y
-20.5
Median 5Y
-20.2
Industry
21.6
vs History
0
vs Industry
Median 3Y
-20
Median 5Y
-19.4
Industry
25.2
vs History
69
vs Industry
41
Median 3Y
3.2
Median 5Y
3.9
Industry
2.5
vs History
80
vs Industry
64
Median 3Y
6.5
Median 5Y
17.4
Industry
7.7
Forward
4.1
vs History
52
vs Industry
63
Median 3Y
6.9
Median 5Y
5.2
Industry
9
vs History
vs Industry
Median 3Y
-10.2
Median 5Y
-11.8
Industry
4.2
Forward
24.7
vs History
vs Industry
Median 3Y
-9.1
Median 5Y
-11.2
Industry
4.1
Forward
197
vs History
0
vs Industry
Median 3Y
-16.6
Median 5Y
-16.3
Industry
5.7
vs History
0
vs Industry
Median 3Y
-16.3
Median 5Y
-16.1
Industry
3.6
vs History
76
vs Industry
42
Median 3Y
6.2
Median 5Y
17.4
Industry
4.6

Multiples Across Competitors

AUPH Competitors Multiples
Aurinia Pharmaceuticals Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
1.3B USD 5.8 -56.8 -182.3 -39.5
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 083 264.3 -181 004.1 -219 796.6 -217 288.5
US
Abbvie Inc
NYSE:ABBV
312.7B USD 5.6 61.5 15.3 23.6
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 4.9 37.4 17.5 33.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 10.9 -241.6 24 25.2
US
Gilead Sciences Inc
NASDAQ:GILD
112.4B USD 4 891.9 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 849.9 -472 -514.1 -500.3
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 5.9 17.8 16.2 18
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.6 -58.7 -53
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.5 -129.9 -104.5 -76.2
P/E Multiple
Earnings Growth
CA
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Average P/E: 208.3
Negative Multiple: -56.8
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -181 004.1 N/A
US
Abbvie Inc
NYSE:ABBV
61.5
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -241.6
42%
US
Gilead Sciences Inc
NASDAQ:GILD
891.9
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.6 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
CA
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Average EV/EBITDA: 17.2
Negative Multiple: -182.3
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 796.6 N/A
US
Abbvie Inc
NYSE:ABBV
15.3
29%
US
Amgen Inc
NASDAQ:AMGN
17.5
62%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
43%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
16%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.1 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
35%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
EV/EBIT Multiple
EBIT Growth
CA
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Average EV/EBIT: 22.5
Negative Multiple: -39.5
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 288.5 N/A
US
Abbvie Inc
NYSE:ABBV
23.6
88%
US
Amgen Inc
NASDAQ:AMGN
33.1
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -500.3 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.2 N/A

See Also

Discover More
Back to Top